Bamlanivimab and Etesevimab Infusion

Name: Negotiated commercial rates for Bamlanivimab and Etesevimab Infusion (HCPCS M0245), in Delaware
Creator: Tynbil
License: https://tynbil.com/terms

Delaware rates for HCPCS M0245

Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring

Rates data updated July 2026.

Rates by insurance carrier

Insurance Carrier	Facility/Professional	Modifier	Typical Low	Median	Typical High